Biomedical Science Equipment Supplied In Ohio

We are currently developing a novel protocol that will use only small molecules to make human cortical interneurons of the forebrain from induced pluripotent stem cells (iPSCs). Our dopaminergic neurons can be used to accelerate the drug discovery process for treatments of neuropsychiatric disorders, schizophrenia, autism, and intellectual ...

We are developing human red blood cells (Erythrocytes) from induced pluripotent stem cells (iPSCs) in a two-step process (iPSCs to HSCs and HSCs to Erythrocytes). Our novel protocols will use small molecules to make red blood cells, which will allow production of red blood cells at scale. We will use our red blood cells as the foundation for a cell therapy for the treatment of blood loss and ...

We are developing these specialized human cells from human (non-embryo) induced pluripotent stem cells (iPSCs) using our proprietary HD-DOE™ research and development platform. We already have a nascent protocol for the generation of hypothalamic NPY-expressing cells. We believe that the delivery of specific subsets of hypothalamic cells from iPSC would be a gate-opener for the drug ...

We are developing human endothelial cells from human (non-embryo) induced pluripotent stem cells (iPSCs). Our novel protocol will allow us to make endothelial cells at scale. We will make our endothelial cells available for drug discovery, organ or tissue printing, high throughput or high content screening, toxicity and efficacy testing, and human disease modeling. ...

Krabbe disease is a devastating neurodegenerative disease affecting about 1 -2.5 in 100,000 people in the U.S. and is inherited in an autosomal recessive manner. Krabbe disease is caused by loss-of-function mutations in the galactosylceramidase (GALC) gene, a lysosomal enzyme responsible for the breakdown of certain types of lipids such as psychosine. Without functional GALC, psychosine ...

We have developed a novel three-stage protocol that uses only small molecules to make human oligodendrocyte progenitor cells (OPCs) of the forebrain from induced pluripotent stem cells ...

We are currently developing a novel protocol that will use only small molecules to make human medium spiny neurons from human (non-embryo) induced pluripotent stem cells (iPSCs). We will use our medium spiny neurons as the foundation for a cell transplantation therapy for treating Huntington’s Disease, which we are ...

We are developing human platelets (Megakaryocytes) from human (non-embryo) induced pluripotent stem cells (iPSCs) in a two-step process (iPSCs to HSCs and HSCs to Megakaryocytes). Our novel protocols will use small molecules to make platelets, which will allow production of platelets at scale. We will use our platelets as the foundation for a cell therapy for the treatment of blood loss and ...

Each wall mounted Bleeding Control Station contains eight Bleeding Control Kits and a disposable litter. The kits are perforated to ensure that they can be detached and opened quickly and easily. Every second of the Platinum Ten minutes counts (highlighted in recent medical research as the key time in which you can save lives) and this kit will help you to help others. ...

Stainless Steel Casework, including metal wall cabinets, is a prominent solution in laboratory furniture due to its exceptional durability, hygiene, and aesthetic appeal. Highly customizable, these cabinets can be adapted to any specific laboratory requirements, offering flexibility in the number of doors, drawers, and overall dimensions. Stainless steel is a dominating choice in demanding ...

Invitrogen TrueCut HiFi Cas9 Protein is a high fidelity CRISPR Cas9 protein variant engineered to demonstrate superior off-target profiles, while preserving maximum on-target editing efficiency. TrueCut HiFi Cas9 Protein is ideal for applications that are sensitive to off-target events and when more precise editing is ...